BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Sunflower Therapeutics Engages PharmNXT Biotech LLP as Distributor for the Daisy Petal™ Perfusion Bioreactor System

  February 26, 2025

   · 

  3 min read
• Press Releases

  Nielsen BioSciences Successfully Completes Enrollment into Phase 3 Trial of CANDIN for the Treatment of Common Warts

  February 26, 2025

   · 

  3 min read
• Press Releases

  MAAST DIGITAL Unveils AI-Powered ERMA Evaluate™: A Revolutionary Platform Set to Transform the Traditional Medical, Legal and Regulatory Review Process for Life Science Companies

  February 26, 2025

   · 

  2 min read
• Press Releases

  RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders

  February 26, 2025

   · 

  9 min read
• Press Releases

  AIM ImmunoTech Appoints David Chemerow to Board of Directors as an Independent Director

  February 26, 2025

   · 

  3 min read
• Press Releases

  FoRx Therapeutics Appoints Chief Medical Officer and Provides an Update on Its Lead Development Candidate

  February 26, 2025

   · 

  4 min read
• Press Releases

  Biosimilars Market Size Estimated to Reach USD 175.99 Billion by 2034

  February 26, 2025

   · 

  1 min read
• Press Releases

  Gene Editing Market Size to Exceed USD 40.10 Billion by 2034

  February 26, 2025

   · 

  1 min read
• Press Releases

  Personalized Medicine Market Size to Increase USD 1,315.43 Billion by 2034

  February 26, 2025

   · 

  1 min read
• 

  Press Releases

  Maxwell Biosciences Secures US Military Research Agreement to Combat Dengue Fever

  U.S. Naval Infectious Diseases Diagnostic Laboratory to study dengue fever activity of Claromer antiviral compounds, combatting a rapidly growing mosquito-borne viral infection and a national priority biodefense threat

  February 26, 2025

   · 

  4 min read